Real-World Treatment Patterns and Overall Survival Among Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients: A Retrospective Cohort Study Using Claims Data

被引：0
|
作者：
Huntington, Scott F. [1 ]
Chang, Hsien-Yen [2 ]
Fu, Alex Z. [2 ,3 ]
Loefgren, Christina [4 ]
Lu, Xiaoxiao [5 ]
机构：
[1] Yale Univ, Div Hematol, New Haven, CT USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[4] Janssen Global Serv LLC, Raritan, NJ USA
[5] Janssen Sci Affairs LLC, Real World Value & Evidence, Horsham, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178755
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
    Buhl, Roland
    Wilke, Thomas
    Picker, Nils
    Schmidt, Olaf
    Hechtner, Marlene
    Kondla, Anke
    Maywald, Ulf
    Vogelmeier, Claus F.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2355 - 2367
  • [32] Real World Treatment Patterns and Outcomes of Venetoclax (Ven) and Hypomethylating Agents (HMA) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States
    Vachhani, Pankit
    Abbas, Jonathan A.
    Flahavan, Evelyn M.
    Ma, Esprit
    Xu, Tao
    Jin, Huan
    Montez, Melissa
    Huang, Weize
    Gershon, Anda
    Ku, Grace
    Flores, Brannon
    Onishi, Maika
    Bui, Cat N.
    Donnellan, William
    BLOOD, 2021, 138
  • [33] Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
    Osterroos, Albin
    Eriksson, Anna
    Antunovic, Petar
    Cammenga, Jorg
    Deneberg, Stefan
    Lazarevic, Vladimir
    Lorenz, Fryderyk
    Mollgard, Lars
    Derolf, Asa R.
    Uggla, Bertil
    Wennstrom, Lovisa
    Olander, Emma
    Hoglund, Martin
    Juliusson, Gunnar
    Lehmann, Soren
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (01) : E13 - +
  • [34] An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
    Swan Lin
    Naveed Shaik
    Geoffrey Chan
    Jorge E. Cortes
    Ana Ruiz-Garcia
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 451 - 459
  • [35] An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
    Lin, Swan
    Shaik, Naveed
    Chan, Geoffrey
    Cortes, Jorge E.
    Ruiz-Garcia, Ana
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) : 451 - 459
  • [36] Gilteritinib and Venetoclax for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia - a Real-World Multicenter Retrospective Study
    Kugler, Eitan
    Cohen, Inbar
    Ram, Ron
    Canaani, Jonathan
    Amitai, Irina
    Shargian, Liat
    Nachmias, Boaz
    Krayem, Baher
    Frisch, Avraham
    Levi, Itay
    Akria, Luiza
    Raanani, Pia
    Wolach, Ofir
    Kugler, Eitan
    BLOOD, 2023, 142
  • [37] AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
    Todisco, Elisabetta
    Papayannidis, Cristina
    Fracchiolla, Nicola
    Petracci, Elisabetta
    Zingaretti, Chiara
    Vetro, Calogero
    Martelli, Maria Paola
    Zappasodi, Patrizia
    Di Renzo, Nicola
    Gallo, Susanna
    Audisio, Ernesta
    Griguolo, Davide
    Cerchione, Claudio
    Selleri, Carmine
    Mattei, Daniele
    Bernardi, Massimo
    Fumagalli, Monica
    Rizzuto, Giuliana
    Facchini, Luca
    Basilico, Claudia Maria
    Manfra, Ilenia
    Borlenghi, Erika
    Cairoli, Roberto
    Salutari, Prassede
    Gottardi, Michele
    Molteni, Alfredo
    Martini, Vincenza
    Lunghi, Monia
    Fianchi, Luana
    Cilloni, Daniela
    Lanza, Francesco
    Abruzzese, Elisabetta
    Cascavilla, Nicola
    Rivellini, Flavia
    Ferrara, Felicetto
    Maurillo, Luca
    Nanni, Jacopo
    Romano, Alessandra
    Cardinali, Valeria
    Gigli, Federica
    Roncoroni, Elisa
    Federico, Vincenzo
    Marconi, Giovanni
    Volpi, Roberta
    Sciume, Mariarita
    Tarella, Corrado
    Rossi, Giuseppe
    Martinelli, Giovanni
    CANCER, 2023, 129 (07) : 992 - 1004
  • [38] Streamline - Retrospective Cohort Study of FLT3-mutated Acute Myeloid Leukemia (AML): Real-World Treatment Patterns and Clinical Outcomes after First Relapse or Refractory (R/R) Diagnosis
    Zeidan, Amer M.
    Gautam, Santosh
    Yu, Rebekah
    Lan, Ziyu
    Grinblatt, David L.
    ElSouda, Dina
    Spalding, James
    Block, Alana
    Touya, Maelys
    Pandya, Bhavik J.
    BLOOD, 2022, 140 : 8124 - 8126
  • [39] Trends on treatment patterns in patients with newly diagnosed AML: Preliminary findings from a real-world analysis
    Alessandrini, Ester Rita
    Moreira, Jeverson
    Simon, Virginie
    Mallet, Oscar
    Gamaoun, Rihab
    Pean, Romane
    Hamkoung, Gauvain
    Zuo, Yue
    Reppelin, Theophile
    Kertous, Mehdi
    Templier, Alexandre
    Mounedji, Nadjat
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Treatment patterns, economic burden, and overall survival in US Medicare Advantage beneficiaries newly diagnosed with acute myeloid leukemia (AML) in 2015-2020
    Huntington, Scott F.
    Ingham, Michael P.
    Okonkwo, Linda
    Singh, Ajaybir
    Wang, Ruibin
    Ammann, Eric M.
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1180 - 1190
12345